Functional assays confirmed that silencing PTPN12, YTHDC2 and MAPKAPK3, or overexpressing GPX3, RASA3 and TSPAN4, significantly suppressed DCIS cell invasion. The gene discussed is TSPAN4; the disease is ductal breast carcinoma in situ.